rs768219929
Positions:
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PP3_Strong
The NM_001080.3(ALDH5A1):c.589G>A(p.Val197Met) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000639 in 1,613,018 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.000033 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000067 ( 0 hom. )
Consequence
ALDH5A1
NM_001080.3 missense
NM_001080.3 missense
Scores
15
3
1
Clinical Significance
Conservation
PhyloP100: 9.59
Genes affected
ALDH5A1 (HGNC:408): (aldehyde dehydrogenase 5 family member A1) This protein belongs to the aldehyde dehydrogenase family of proteins. This gene encodes a mitochondrial NAD(+)-dependent succinic semialdehyde dehydrogenase. A deficiency of this enzyme, known as 4-hydroxybutyricaciduria, is a rare inborn error in the metabolism of the neurotransmitter 4-aminobutyric acid (GABA). In response to the defect, physiologic fluids from patients accumulate GHB, a compound with numerous neuromodulatory properties. Two transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.947
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ALDH5A1 | NM_001080.3 | c.589G>A | p.Val197Met | missense_variant | 3/10 | ENST00000357578.8 | NP_001071.1 | |
ALDH5A1 | NM_170740.1 | c.589G>A | p.Val197Met | missense_variant | 3/11 | NP_733936.1 | ||
ALDH5A1 | NM_001368954.1 | c.589G>A | p.Val197Met | missense_variant | 3/9 | NP_001355883.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ALDH5A1 | ENST00000357578.8 | c.589G>A | p.Val197Met | missense_variant | 3/10 | 1 | NM_001080.3 | ENSP00000350191 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000328 AC: 5AN: 152222Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
5
AN:
152222
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000440 AC: 11AN: 250134Hom.: 0 AF XY: 0.0000517 AC XY: 7AN XY: 135298
GnomAD3 exomes
AF:
AC:
11
AN:
250134
Hom.:
AF XY:
AC XY:
7
AN XY:
135298
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000671 AC: 98AN: 1460796Hom.: 0 Cov.: 33 AF XY: 0.0000647 AC XY: 47AN XY: 726734
GnomAD4 exome
AF:
AC:
98
AN:
1460796
Hom.:
Cov.:
33
AF XY:
AC XY:
47
AN XY:
726734
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152222Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74362
GnomAD4 genome
AF:
AC:
5
AN:
152222
Hom.:
Cov.:
32
AF XY:
AC XY:
3
AN XY:
74362
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
2
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:9Benign:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Succinate-semialdehyde dehydrogenase deficiency Pathogenic:1Uncertain:3Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 05, 2022 | This sequence change replaces valine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 197 of the ALDH5A1 protein (p.Val197Met). This variant is present in population databases (rs768219929, gnomAD 0.01%). This missense change has been observed in individual(s) with succinic semialdehyde dehydrogenase (PMID: 25431891). ClinVar contains an entry for this variant (Variation ID: 356132). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on ALDH5A1 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Likely pathogenic, criteria provided, single submitter | curation | Elsea Laboratory, Baylor College of Medicine | Mar 08, 2021 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | New York Genome Center | Jun 05, 2020 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jul 10, 2016 | The ALDH5A1 c.589G>A (p.Val197Met) variant is a missense variant that has been reported in a compound heterozgyous state with a second missense variant in a child with succinic semialdehyde dehydrogenase (SSADH) deficiency (Liu et al. 2014). Family studies revealed that the child inherited the p.Val197Met variant from his mother and the second missense variant from his father. The p.Val197Met variant was absent from 100 healthy ethnically matched control individuals and is reported at a frequency of 0.000196 in the African population of the Exome Aggregation Consortium. This frequency is based on two alleles in a region of good sequencing coverage, so the variant is presumed to be rare. The evidence for this variant is limited. The p.Val197Met variant is thus classified as a variant of unknown significance but suspicious for pathogenicity for succinic semialdehyde dehydrogenase deficiency. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. - |
Likely benign, criteria provided, single submitter | clinical testing | 3billion | Sep 20, 2024 | The homozygous variant was found in patients diagnosed with another variant in a different gene, with no symptoms related to the gene containing the homozygous variant. - |
not provided Uncertain:4
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Nov 14, 2017 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Mar 11, 2024 | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 26268900, 27268762, 12743223, 32402538, 34426522, 33203024, 25431891) - |
Uncertain significance, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Uncertain significance, no assertion criteria provided | clinical testing | Department of Pathology and Laboratory Medicine, Sinai Health System | - | The ALDH5A1 p.Val197Met variant was identified in dbSNP (ID: rs768219929) as "With Uncertain significance allele" and in Clinvar (classified as VUS by Ambry Genetics, Illumina Clinical Services, and EGL Diagnostics with the associated conditions of Succinate-semialdehyde dehydrogenase deficiency and inborn genetic diseases). The variant was not identified in Cosmic and LOVD 3.0 databases. The variant was also found in control databases in 12 of 281530 chromosomes at a frequency of 0.000043 (Genome Aggregation Database Feb 27, 2017), in the following populations: Latino in 5 of 35406 chromosomes (freq: 0.000141), Other in 1 of 7202 chromosomes (freq: 0.000139), African in 2 of 24914 chromosomes (freq: 0.00008) and European (non-Finnish) in 4 of 128826 chromosomes (freq: 0.000031), while the variant was not observed in the Ashkenazi Jewish, East Asian, European (Finnish) and South Asian populations. In a case study, genetic analysis of ALDH5A1 was performed for a male child with SSADH deficiency, his parents, and their 10 weeks' gestation at-risk fetus as well as 100 healthy unrelated volunteers. The proband was identified to have compound heterozygous mutations c.496T>C (p.W166R) and c.589G>A (p.V197M). Each of his parents carried a mutation. DNA sequencing of chorionic villus revealed the fetus was a carrier and this was confirmed after birth by genetic analysis of umbilical cord blood and urine organic acid analysis (Liu_2016_PMID: 25431891). The variant occurs outside of the splicing consensus sequence and 1 of 4 in silico or computational prediction software programs (SpliceSiteFinder) predict a greater than 10% difference in splicing (gain of a 5' splice site at c.586). The p.Val197 residue is conserved in mammals and computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) provide inconsistent predictions regarding the impact to the protein; this information is not very predictive of pathogenicity. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Feb 15, 2024 | Variant summary: ALDH5A1 c.589G>A (p.Val197Met) results in a conservative amino acid change located in the Aldehyde dehydrogenase domain (IPR015590) of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 4.4e-05 in 250134 control chromosomes. c.589G>A has been reported in the literature in trans along with an apparently VUS missense in an individual affected with Succinic Semialdehyde Dehydrogenase Deficiency (Liu_2016). These report(s) do not provide unequivocal conclusions about association of the variant with Succinic Semialdehyde Dehydrogenase Deficiency. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication have been ascertained in the context of this evaluation (PMID: 25431891).ClinVar contains an entry for this variant (Variation ID: 356132). Based on the evidence outlined above, the variant was classified as uncertain significance. - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 25, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Pathogenic
DEOGEN2
Pathogenic
D;D;.
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Pathogenic
D;D;D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D;D
MetaSVM
Pathogenic
D
MutationAssessor
Pathogenic
H;.;H
MutationTaster
Benign
D;D;D;D
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;D;D
REVEL
Pathogenic
Sift
Pathogenic
D;D;D
Sift4G
Pathogenic
D;D;D
Polyphen
D;.;.
Vest4
MVP
MPC
0.94
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at